Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-58.55	4.23	10.21
Graham Fair Price	41.42	0.29	0.21
PEG	-31.50	0.04	0.06
Price/Book	-12.50	0.31	0.36
Price/Cash Flow	56.25	-17.29	-39.51
Prices/Earnings	-56.25	4.11	9.40
Price/Sales	-56.25	1.06	2.41
Price/FCF	56.25	-17.29	-39.51
Naive Interpretation	member

01 - Valuation · Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.24	0.24
Operating Margin	-6.15	0.07	0.08
ROA	100.00	0.02	< 0.005
ROE	< 0.005	0.02	100.00
ROIC	< 0.005	0.02	85.78
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.21	0.97	-78.06
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	3.39	0.88	-74.15
EPS QOQ	1.53	0.98	-36.14
FCF QOQ	-1.63	-1.00	38.83
Revenue QOQ	-0.53	1.00	89.46
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	330.38	165.19	-50.00
Days Sales Outstanding (DSO)	131.12	66.07	-49.61
Inventory Turnover	0.27	0.54	100.00
Debt/Capitalization	0.05	0.06	20.04
Quick Ratio	3.40	3.41	0.53
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.45	0.45	0.00
Cash	0.05	0.05	0.00
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	< 0.005	< 0.005	-100.00
Revenue	0.07	0.13	100.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	8.15	8.15	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.69	-0.62	63.25
Naive Interpretation	Member

06 - Financial Health · Bad

Rating